What side effects are associated with this type of intervention?

The most common treatments for appendicitis, particularly antibiotic irrigation with gentamicin and clindamycin, can have several side effects. Gentamicin may cause nephrotoxicity and ototoxicity, while clindamycin can lead to gastrointestinal disturbances, including diarrhea and potentially severe Clostridioides difficile infection. Local application of these antibiotics may reduce systemic side effects but can still cause localized irritation or allergic reactions.

What prior FDA approvals exist?

The FDA has approved various antibiotics for the treatment of appendicitis, particularly for cases involving infection or risk of infection. Commonly used antibiotics include broad-spectrum agents such as piperacillin-tazobactam, cephalosporins, and metronidazole. While specific FDA approvals for local antibiotic applications like gentamicin/clindamycin irrigation in appendicitis are not detailed, these antibiotics are widely used in clinical practice for their efficacy in preventing postoperative infections. The study of gentamicin/clindamycin solution for local antibiotic application during laparoscopic appendectomy represents an innovative approach to reducing wound infections and intra-abdominal abscesses in pediatric patients with perforated appendicitis.

What other types of research exist?

Promising novel alternatives to antibiotic irrigation for appendicitis patients include: 1) Use of antimicrobial-coated implants or materials that reduce bacterial adherence and infection risk. 2) Application of hydrophilic coatings on surgical instruments that absorb and release antibiotics locally. 3) Implementation of advanced wound care techniques such as negative pressure wound therapy (NPWT) to enhance healing and reduce infection rates. 4) Utilization of bacteriophage therapy, which targets specific bacterial pathogens without affecting the normal microbiota. 5) Adoption of enhanced recovery protocols that optimize perioperative care and minimize infection risks.

← Back to Search

Anti-bacterial Agent

Antibiotic Irrigation for Appendicitis (PA protocol Trial)

Phase 2

Waitlist Available

Led By Robert Gates, MD

Research Sponsored by Prisma Health-Upstate

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Scheduled to undergo laparoscopic appendectomy

Male or female, age 18 years or younger

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 30 days

Awards & highlights

PA protocol Trial Summary

This trial will compare two methods of preventing infection during surgery for appendicitis. One method uses a suction device without irrigation and the other uses a gentamicin/clindamycin solution.

Who is the study for?

This trial is for children and teenagers up to 18 years old who are scheduled for laparoscopic surgery due to perforated appendicitis. Participants must be willing to follow the treatment plan and come back for check-ups. Pregnant individuals or those not consenting to the study's procedures cannot join.Check my eligibility

What is being tested?

The study is testing if rinsing out the appendix area with antibiotics (gentamicin/clindamycin) during surgery helps prevent infections better than just using suction without any rinse. Kids in this study will randomly get one of these two treatments.See study design

What are the potential side effects?

Possible side effects may include reactions to the antibiotic solution, such as allergic responses or irritation at the site where surgery was done. The exact side effects will depend on how each child reacts to the antibiotic.

PA protocol Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am scheduled for a laparoscopic surgery to remove my appendix.

Select...

I am 18 years old or younger.

Select...

My appendix was found to be ruptured before or during surgery.

Select...

My appendix was found to be ruptured before or during surgery.

PA protocol Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 30 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~30 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

wound complications

PA protocol Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Antibiotic irrigation with suctionExperimental Treatment1 Intervention

Group A: You will receive antibiotic irrigation with suction if a PA is found during surgery

Group II: suction onlyActive Control1 Intervention

Group B: You will receive suction alone if a PA is found during surgery

0 / 4Eligibility criteria met

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.

Mechanism Of Action

Side Effect Profile

Prior Approvals

Other Research

The primary treatment for appendicitis is surgical removal of the appendix (appendectomy), which can be performed via open surgery or laparoscopically. Antibiotic therapy is also crucial, especially in cases of perforated appendicitis, to prevent and treat infections. Gentamicin and clindamycin are antibiotics used for their broad-spectrum activity against gram-negative and anaerobic bacteria, respectively. When used in local antibiotic irrigation during surgery, these antibiotics directly target the infected area, reducing bacterial load and preventing postoperative infections. This localized approach minimizes systemic side effects and enhances the effectiveness of infection control, which is vital for improving patient outcomes and reducing complications in appendicitis treatment.

Find a Location

Who is running the clinical trial?

Prisma Health-UpstateLead Sponsor

83 Previous Clinical Trials

42,828 Total Patients Enrolled

Robert Gates, MDPrincipal InvestigatorPrisma Health

~16 spots leftby Dec 2024

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.